Day: March 12, 2026

Celularity Reiterates Strategic Commercialization Partnership with NEXGEL Focused on Building Biomaterials Franchise with Established Commercial Products and New 510(k) Pathway Product Opportunities

Biovance, Biovance 3L, Natalin, Acelagraft, Interfyl and Centaflex licensed to NEXGEL are established commercial products widely used today in wound...

Black Book Unveils 2026 South Africa Acute Care EHR Report as NHI, POPIA, and Infrastructure Gaps Redefine Hospital IT Priorities

New market intelligence finds South Africa's healthcare digital transformation accelerating along a "two-speed" path, with private-sector modernization outpacing much of...

Ultragenyx Announces Positive 36-Week Data from Phase 3 Study of DTX301 AAV8 Gene Therapy for the Treatment of Ornithine Transcarbamylase (OTC) Deficiency

Statistically significant improvements in primary endpoint of ammonia control compared with placebo at 36 weeks Clinically important changes observed in...

Medical Care Technologies Inc. (OTC Pink:MDCE) Snapshot Recipes Ignites First Successful Monetization of AI Technology in the Smart Device Market

"AI-Powered Recipe App Gains Momentum with Top 50 Ranking in Apple's Food & Drink Category, Growing Social Media Buzz, and...

Cadrenal Therapeutics Highlights Research Supporting 12-LOX Inhibition in Reducing Inflammation in Obesity and Type 2 Diabetes

PONTE VEDRA, Fla., March 12, 2026 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing innovative treatments...

Calidi Biotherapeutics Presents its Innovative and Scalable Manufacturing Process for CLD-401 at the 9th Annual Bioprocessing Summit; FDA Feedback Support Company’s Approach to Manufacturing

SAN DIEGO, March 12, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology...

error: Content is protected !!